Alvara Therapeutics Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $651K

  • Investors
  • 2

Alvara Therapeutics General Information

Description

Developer of small-molecule medicines designed to treat chronic kidney disease. The company uses fragment-based drug discovery and structural biology to develop inhibitors of the Keap1-Nrf2 interaction, enabling the activation of antioxidant and anti-inflammatory proteins to help preserve kidney function.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Ole Maaløes Vej 3
  • Copenhagen North
  • 2200 Copenhagen
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Ole Maaløes Vej 3
  • Copenhagen North
  • 2200 Copenhagen
  • Denmark

Alvara Therapeutics Timeline

Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alvara Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 16-Sep-2026 $651K Completed Startup
1. University Spin-Out 10-Jul-2026 Completed Startup
To view Alvara Therapeutics’s complete valuation and funding history, request access »

Alvara Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alvara Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioInnovation Institute Accelerator/Incubator
University of Copenhagen University
To view Alvara Therapeutics’s complete investors history, request access »

Alvara Therapeutics FAQs

  • When was Alvara Therapeutics founded?

    Alvara Therapeutics was founded in 2026.

  • Where is Alvara Therapeutics headquartered?

    Alvara Therapeutics is headquartered in Copenhagen, Denmark.

  • What is the size of Alvara Therapeutics?

    Alvara Therapeutics has 3 total employees.

  • What industry is Alvara Therapeutics in?

    Alvara Therapeutics’s primary industry is Drug Discovery.

  • Is Alvara Therapeutics a private or public company?

    Alvara Therapeutics is a Private company.

  • What is Alvara Therapeutics’s current revenue?

    The current revenue for Alvara Therapeutics is .

  • How much funding has Alvara Therapeutics raised over time?

    Alvara Therapeutics has raised $651K.

  • Who are Alvara Therapeutics’s investors?

    BioInnovation Institute and University of Copenhagen have invested in Alvara Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process